EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid Disorders Management Strategies (2024) in Prediabetic and Diabetic Patients

Laura Gaita iD, Bogdan Timar, Romulus Timar, Zlatko Fras iD, Dan Gaita iD, Maciej Banach iD

Pharmaceuticals · 07.02.2024 · 17 (2) · 219

DOI: 10.3390/ph17020219 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 07.02.2024. Verfasst von Laura Gaita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Internal Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dyslipidaemia is a modifiable risk factor commonly associated with diabetes mellitus and prediabetes, with a major impact on the early development of atherosclerotic cardiovascular disease. Various studies have tried to identify the key treatment targets, their optimal values according to patients’ CV risk, and the most efficient yet safe therapeutic agents which, alongside lifestyle changes, would improve lipid levels and reduce cardiovascular mortality and morbidity. Currently, there are multiple pharmacologic options that can be used in the management of dyslipidaemia, such as statins, ezetimibe, bempedoic acid, PCSK9 inhibitors, n-3 polyunsaturated fatty acids or fibrates, to name only a few, while many other are under development. In the current setting of a continuously increasing population of patients with metabolic disorders, this review aims to summarise current knowledge regarding lipid disorders and the recommendations of recent guidelines in treating dyslipidaemia in patients with diabetes mellitus or prediabetes.

Schlagwörter

Stichwörter der Autor:innen

LDLcatherogenic dyslipidaemiacardiovascular riskdiabetes mellituslipid-lowering pharmacologic agentsnon-HDLcprediabetestreatment targets

Autor:innen und Institutionen

  • Second Department of Internal Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • "Pius Brinzeu" Emergency Hospital, 300723 Timisoara, Romania.
  • Department of Vascular Disease, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
  • Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • Department of Cardiology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Institutul de Boli Cardiovasculare, 300310 Timisoara, Romania.

ORCID-Profile: Laura Gaita, Zlatko Fras, Dan Gaita, Maciej Banach

Zitieren

APA

Gaita, L., Timar, B., Timar, R., Fras, Z., Gaita, D., & Banach, M. (2024). Lipid Disorders Management Strategies (2024) in Prediabetic and Diabetic Patients. Pharmaceuticals, 17(2), 219. https://doi.org/10.3390/ph17020219

Vancouver

Gaita L, Timar B, Timar R, Fras Z, Gaita D, Banach M. Lipid Disorders Management Strategies (2024) in Prediabetic and Diabetic Patients. Pharmaceuticals. 2024;17(2):219. doi:10.3390/ph17020219

BibTeX
@article{Gaita2024,
  author = {Gaita, Laura and Timar, Bogdan and Timar, Romulus and Fras, Zlatko and Gaita, Dan and Banach, Maciej},
  title = {Lipid Disorders Management Strategies (2024) in Prediabetic and Diabetic Patients},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {2},
  pages = {219},
  doi = {10.3390/ph17020219}
}
Kostenlos starten →